Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access

Contributed by: Business Wire

Logo

Images

(Graphic: Business Wire)

Business Wire embedded0

Tags

Technology

Biotechnology

Health

Robotics

Wearables/Mobile Technology

Pharmaceutical

Surgery

Artificial Intelligence

Research

Medical Devices

Software

Health Technology

Science

Clinical Trials

acquisition of HULL ASSOCIATES LLC and Ironstone Product Development (IPD)

More Like This

Avania, the leading, global medical technology contract research organization and advisory services partner, announces its acquisition of Anagram. (Graphic: Business Wire)

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

Avania Strengthens Leadership Team with Appointment of Four New Executives

Jason Monteleone, newly appointed president and CEO of Avania. (Photo: Business Wire)

Avania Appoints Recognized CRO and MedTech Industry Leader, Jason Monteleone, as New President and CEO

Jasmine Saba (left) has been appointed Sr. Vice President of Strategic Relationships. Josh Blacker (right) joins Avania as Sr. Vice President of Global Business Development.

Avania Strengthens Leadership Team With Pivotal Executive Appointments

Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)

Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

Avantia, Hoxton Ventures’ Portfolio Company, Acquired By Carta

Veranex launches Innovation CRO for device and diagnostics.

Veranex Unveils MedTech’s First Innovation CRO (iCRO)—Redefining R&D in a Capital‑Tight Market

PDV MedTech and Corscience Announce Strategic Partnership to Advance MedTech Development and Manufacturing Across the US and Europe